Depomed Inc - Company & Market Research Reports

Depomed is an American specialty pharmaceutical company, which mainly markets products for treatment in neurology, pain and diseases of the central nervous system. The drug company makes proprietary drug therapies using its patented AcuForm, an extended-release technology. Some of its best known products include Gralise, CAMBIA, Zipsor and Lazanda nasal spray. The company was founded in 1995 and is headquartered in Newark, California.


Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse - Product Thumbnail Image

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

  • Report
  • 147 Pages
From
Market Spotlight: Neuropathic Pain - Product Thumbnail Image

Market Spotlight: Neuropathic Pain

  • Report
  • 36 Pages
From
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets - Product Thumbnail Image

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • Report
  • 126 Pages
From
Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems) - Product Thumbnail Image

Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)

  • Report
  • 475 Pages
From
The Global Market for Pain Management Drugs and Devices - Product Thumbnail Image

The Global Market for Pain Management Drugs and Devices

  • Report
  • 251 Pages
From
United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development) - Product Thumbnail Image

United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development)

  • Report
  • 77 Pages
From
Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era - Product Thumbnail Image

Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era

  • Report
  • 135 Pages
From
Zipsor 2016 U.S Promotional Report - Product Thumbnail Image

Zipsor 2016 U.S Promotional Report

  • Report
  • 30 Pages
From
Lazanda 2016 U.S Promotional Report - Product Thumbnail Image

Lazanda 2016 U.S Promotional Report

  • Report
  • 28 Pages
From
Gralise 2016 U.S Promotional Report - Product Thumbnail Image

Gralise 2016 U.S Promotional Report

  • Report
  • 28 Pages
From
Cambia 2016 U.S Promotional Report - Product Thumbnail Image

Cambia 2016 U.S Promotional Report

  • Report
  • 28 Pages
From
Nucynta 2016 U.S Promotional Report - Product Thumbnail Image

Nucynta 2016 U.S Promotional Report

  • Report
  • 30 Pages
From
The Global Pain Therapeutics Market, 5th Edition: Market Trends & R&D Insights - Product Thumbnail Image

The Global Pain Therapeutics Market, 5th Edition: Market Trends & R&D Insights

  • Report
  • 536 Pages
From
The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide - Product Thumbnail Image

The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide

  • Report
  • 235 Pages
From
Global Neuropathy Pain Treatment Market 2017-2021 - Product Thumbnail Image

Global Neuropathy Pain Treatment Market 2017-2021

  • Report
  • 70 Pages
From
Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments - Product Thumbnail Image

Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

  • Report
  • 136 Pages
From
PharmaPoint: Painful Diabetic Neuropathy - Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

PharmaPoint: Painful Diabetic Neuropathy - Global Drug Forecast and Market Analysis to 2026

  • Report
  • 218 Pages
From
Postherpetic Neuralgia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Postherpetic Neuralgia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

  • Drug Pipelines
  • 100 Pages
From
Controlled Release Drug Delivery Market Analysis Report By Technology (Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Controlled Release Drug Delivery Market Analysis Report By Technology (Transdermal, Microencapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2018 - 2025

  • Report
  • 143 Pages
From
Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 - Product Thumbnail Image

Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021

  • Report
  • 382 Pages
From
Loading Indicator
adroll